(Q38104247)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644748%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Engineering of bacterial strains and their products for cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644748%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644748%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Arsenio M. Fialho

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644748%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Ananda M Chakrabarty

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644748%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

4 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644748%20AND%20SRC:MED&resulttype=core&format=json

Applied Microbiology and Biotechnology

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644748%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644748%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644748%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

5189-5199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644748%20AND%20SRC:MED&resulttype=core&format=json

Overcoming drug resistance in multi-drug resistant cancers and microorganisms: a conceptual framework

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Bacteria as vectors for gene therapy of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Visualizing implanted tumors in mice with magnetic resonance imaging using magnetotactic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Microbial-based therapy of cancer: current progress and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Therapeutic live vaccines as a potential anticancer strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Microorganisms and Cancer: Quest for a Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Targeting cancer with bugs and liposomes: ready, aim, fire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Therapeutic potential of anticancer immunotoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Recombinant Escherichia coli expressing invasin targets the Peyer's patches: the basis for a bacterial formulation for oral vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Combination bacteriolytic therapy for the treatment of experimental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Docking study and free energy simulation of the complex between p53 DNA-binding domain and azurin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Recent patents on live bacteria and their products as potential anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Glioblastoma multiforme: novel therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Engineering the perfect (bacterial) cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Functional and structural characteristics of anticancer peptide Pep27 analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Human toxin-based recombinant immunotoxins/chimeric proteins as a drug delivery system for targeted treatment of human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Minicells: versatile vectors for targeted drug or si/shRNA cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Tumour targeting with systemically administered bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Immunotoxin treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Bacteria in cancer therapy: a novel experimental strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Bacterial cupredoxin azurin and its interactions with the tumor suppressor protein p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Genomic variation landscape of the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

21 January 2018

Combating chlamydiosis

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Probing the interaction between p53 and the bacterial protein azurin by single molecule force spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Noncationic peptides obtained from azurin preferentially enter cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Oral cytokine gene therapy against murine tumor using attenuated Salmonella typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Listeria-derived ActA is an effective adjuvant for primary and metastatic tumor immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Apoptosis or growth arrest: Modulation of tumor suppressor p53's specificity by bacterial redox protein azurin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Establishment and characterization of conditions required for tumor colonization by intravenously delivered bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Bacillus calmette-guerin cell wall cytoskeleton enhances colon cancer radiosensitivity through autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Secreted products of a nonmucoid Pseudomonas aeruginosa strain induce two modes of macrophage killing: external-ATP-dependent, P2Z-receptor-mediated necrosis and ATP-independent, caspase-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Drugs from hidden bugs: their discovery via untapped resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-4926-6

10.1007/S00253-013-4926-6

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644748%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 February 2020

1006130640

0 references

Fatcat ID

release_fvwaowdolbeo3djzezpha7guf4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fvwaowdolbeo3djzezpha7guf4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference